tiprankstipranks
Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170)
:2170
Hong Kong Market
Want to see HK:2170 full AI Analyst Report?

Suzhou Basecare Medical Corp. Ltd. Class H (2170) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Suzhou Basecare Medical Corp. Ltd. Class H has a market cap or net worth of HK$519.70M. The enterprise value is HK$251.53M.
Market CapHK$519.70M
Enterprise ValueHK$251.53M

Share Statistics

Suzhou Basecare Medical Corp. Ltd. Class H has 82,713,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding82,713,840
Owned by Insiders
Owned by Institutions

Financial Efficiency

Suzhou Basecare Medical Corp. Ltd. Class H’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -14.97%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-14.97%
Return on Capital Employed (ROCE)-0.16
Revenue Per Employee457.21K
Profits Per Employee-437.97K
Employee Count497
Asset Turnover0.16
Inventory Turnover0.98

Valuation Ratios

The current PE Ratio of Suzhou Basecare Medical Corp. Ltd. Class H is ―. Suzhou Basecare Medical Corp. Ltd. Class H’s PEG ratio is 0.26.
PE Ratio
PS Ratio2.01
PB Ratio0.49
Price to Fair Value0.49
Price to FCF-1.88
Price to Operating Cash Flow-2.99
PEG Ratio0.26

Income Statement

In the last 12 months, Suzhou Basecare Medical Corp. Ltd. Class H had revenue of 227.23M and earned -217.67M in profits. Earnings per share was -0.80.
Revenue227.23M
Gross Profit108.78M
Operating Income-199.48M
Pretax Income-221.31M
Net Income-217.67M
EBITDA-152.37M
Earnings Per Share (EPS)-0.80

Cash Flow

In the last 12 months, operating cash flow was -207.59M and capital expenditures -89.76M, giving a free cash flow of -297.35M billion.
Operating Cash Flow-207.59M
Free Cash Flow-297.35M
Free Cash Flow per Share-3.59

Dividends & Yields

Suzhou Basecare Medical Corp. Ltd. Class H pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.28
52-Week Price Change-40.63%
50-Day Moving Average1.94
200-Day Moving Average2.51
Relative Strength Index (RSI)49.64
Average Volume (3m)121.73K

Important Dates

Suzhou Basecare Medical Corp. Ltd. Class H upcoming earnings date is Aug 31, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date

Financial Position

Suzhou Basecare Medical Corp. Ltd. Class H as a current ratio of 3.98, with Debt / Equity ratio of 33.13%
Current Ratio3.98
Quick Ratio3.34
Debt to Market Cap0.75
Net Debt to EBITDA0.50
Interest Coverage Ratio-15.61

Taxes

In the past 12 months, Suzhou Basecare Medical Corp. Ltd. Class H has paid -3.64M in taxes.
Income Tax-3.64M
Effective Tax Rate0.02

Enterprise Valuation

Suzhou Basecare Medical Corp. Ltd. Class H EV to EBITDA ratio is -2.50, with an EV/FCF ratio of -1.57.
EV to Sales1.68
EV to EBITDA-2.50
EV to Free Cash Flow-1.57
EV to Operating Cash Flow-2.38

Balance Sheet

Suzhou Basecare Medical Corp. Ltd. Class H has HK$545.48M in cash and marketable securities with HK$342.23M in debt, giving a net cash position of HK$203.25M billion.
Cash & Marketable SecuritiesHK$545.48M
Total DebtHK$342.23M
Net CashHK$203.25M
Net Cash Per ShareHK$2.46
Tangible Book Value Per ShareHK$2.56

Margins

Gross margin is 48.99%, with operating margin of -87.78%, and net profit margin of -95.79%.
Gross Margin48.99%
Operating Margin-87.78%
Pretax Margin-97.39%
Net Profit Margin-95.79%
EBITDA Margin-67.05%
EBIT Margin-87.78%

Analyst Forecast

The average price target for Suzhou Basecare Medical Corp. Ltd. Class H is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-21.90%
EPS Growth Forecast5.78%

Scores

Smart Score3
AI Score